Maria Dimou

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin et al. · Leukemia · 2020 · 275 citations · Full text

Medicine, Hematology, Internal Medicine +10

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas, Sabine Jeromin, Michalis Iskas et al. · Blood · 2019 · 237 citations · Full text

Life Sciences, Hematology, Oncology +16

Long‐term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2‐year follow‐up of the CHRONOS‐1 study

Martin Dreyling, Armando Santoro, Luigina Mollica et al. · American Journal of Hematology · 2019 · 172 citations · Full text

Medicine, Oncology, Pharmacology +12

Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma

Marie‐Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Sotirios Sachanas et al. · British Journal of Haematology · 2007 · 129 citations

Medicine, Hematology, Oncology +13

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14